Vanberra Signal
Free trial

Bio-Prodict

Curated by Signal

Developer of a bioinformatics computational platform for the analysis of biological data

Life Sciences Technologybio-prodict.com

Overview

Bio-Prodict is a developer of a bioinformatics computational platform for the analysis of biological data. The company's flagship product includes the 3DM information system which is a protein super-family platform. It is used to collect, combine, and integrate different protein super-family data from various sources. The company integrates its 3DM informatics system with molecular graphics and modelling software YASARA that enables it to visualize the trends in protein structures.

Key facts

Founded
2008
Headquarters
Nijmegen, Netherlands
Stage
Sign up to view
Industry
Life Sciences Technology

Business model

3 products and services
Sign up to view

Contact

Email
Sign up to view
Phone
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

  • Pasithea

    Developer of noninvasive device that detects and treats sleep apnea

    Life Sciences TechnologyAmsterdam, Netherlands

  • IPD

    Provider of treatment for prosthetic joint & metal implant infections

    Life Sciences TechnologyLeiden, Netherlands

  • Nemo Healthcare

    Developer of fetal monitoring technology

    Life Sciences TechnologyVeldhoven, Netherlands

About Bio-Prodict

What does Bio-Prodict do?

Bio-Prodict is a developer of a bioinformatics computational platform for the analysis of biological data.

Where is Bio-Prodict headquartered?

Bio-Prodict is headquartered in Nijmegen, Netherlands.

When was Bio-Prodict founded?

Bio-Prodict was founded in 2008.

Which sector is Bio-Prodict in?

Bio-Prodict operates in Life Sciences Technology.

Who are Bio-Prodict's competitors?

Companies similar to Bio-Prodict include Pasithea, IPD, and Nemo Healthcare.